Details for Patent: 7,820,199

Summary for Patent: 7,820,199

Title:	Stable extended release oral dosage composition
Abstract:	A film-coated extended release solid oral dosage composition containing a nasal decongestant, pseudoephedrine or salt thereof, e.g., pseudoephedrine sulfate in a core effective to provide a geometric maximum plasma concentration of pseudoephedrine of about 345 ng/mL to about 365 ng/mL at a time of about 7.60 hrs to about 8.40 hrs and having two or three film-coatings on the core, the second one containing an amount of the non-sedating antihistamine, desloratadine, effective to provide a geometric maximum plasma concentration of desloratadine of about 2.15 ng/mL to about 2.45 ng/mL at a time of about 4.0 hours to about 4.5 hours, and use of the composition for treating patients showing the signs and symptoms associated with allergic and/or inflammatory conditions of the skin and airway passages are disclosed.
Inventor(s):	Kou; Jim H. (Basking Ridge, NJ)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	11/244,743
Patent Claim Types: see list of patent claims	Compound; Dosage form; Formulation;

Drugs Protected by US Patent 7,820,199

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,820,199

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	027033
Austria	463240
Australia	2005203771
Australia	2009200460
Australia	2277101
Australia	7244300